Advertisement
Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis

October 19, 2021

Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis

Aaron G Lim and colleagues model the health and economic benefits of eliminating hepatitis C in Pakistan.

Image credit: Waqas Aziz, Flickr

10/12/2021

Perspective

ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors

Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.

ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors

Image credit: Aadel Chaudhuri, Angela Hirbe, Jack Shern, Jeff Szymanski, Taylor Sundby, DrawImpacts

Get new content from PLOS Medicine in your inbox

Thank you! You have successfully subscribed to the PLOS Medicine newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again